THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 112 filers reported holding THERAVANCE INC in Q1 2015. The put-call ratio across all filers is 57.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $3,202,000 | +228.1% | 303,799 | +123.5% | 0.00% | – |
| Q3 2015 | $976,000 | -84.8% | 135,898 | -61.9% | 0.00% | -100.0% |
| Q2 2015 | $6,439,000 | +25.6% | 356,314 | +9.3% | 0.00% | +100.0% |
| Q1 2015 | $5,126,000 | -15.7% | 326,126 | -24.1% | 0.00% | -50.0% |
| Q4 2014 | $6,079,000 | +713.8% | 429,613 | +883.0% | 0.00% | – |
| Q3 2014 | $747,000 | -94.9% | 43,703 | -91.1% | 0.00% | -100.0% |
| Q2 2014 | $14,627,000 | +426.0% | 491,188 | +446.5% | 0.01% | +400.0% |
| Q1 2014 | $2,781,000 | -84.6% | 89,881 | -82.3% | 0.00% | -83.3% |
| Q4 2013 | $18,097,000 | +329.3% | 507,612 | +392.1% | 0.01% | +200.0% |
| Q3 2013 | $4,215,000 | -8.0% | 103,143 | -13.3% | 0.00% | 0.0% |
| Q2 2013 | $4,584,000 | +367.3% | 118,974 | +169.7% | 0.00% | – |
| Q4 2012 | $981,000 | -17.4% | 44,111 | -3.7% | 0.00% | – |
| Q3 2012 | $1,187,000 | -8.6% | 45,814 | -21.6% | 0.00% | – |
| Q2 2012 | $1,299,000 | -29.4% | 58,437 | -38.1% | 0.00% | – |
| Q1 2012 | $1,839,000 | – | 94,331 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 19,815,983 | $338,655,000 | 5.90% |
| Litespeed Management, L.L.C. | 2,670,695 | $45,642,000 | 1.76% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,790,913 | $47,697,000 | 1.76% |
| Proxima Capital Management, LLC | 915,000 | $15,637,000 | 1.69% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,196,372 | $140,076,000 | 1.44% |
| PERRY CAPITAL | 1,831,099 | $31,293,000 | 1.14% |
| Roundview Capital LLC | 140,145 | $2,395,000 | 1.08% |
| SECTORAL ASSET MANAGEMENT INC | 971,438 | $16,602,000 | 0.70% |
| Realm Partners LLC | 139,982 | $2,392,000 | 0.68% |
| BB BIOTECH AG | 743,244 | $12,702,000 | 0.52% |